We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Deepmatter Group Plc | LSE:DMTR | London | Ordinary Share | GB00B29YYY86 | ORD 0.01P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 0.0325 | 0.025 | 0.04 | - | 0.00 | 00:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
0 | 0 | N/A | 0 |
Date | Subject | Author | Discuss |
---|---|---|---|
05/8/2021 07:55 | clearly moving in the right direction with this RNS although the share price could do with some revenue announcements - hopefully to follow soon. | ragnarr | |
22/6/2021 14:03 | yeah because it's a p.o.s | the stigologist | |
22/6/2021 13:54 | NT to buy any amount . | wololol | |
01/6/2021 12:14 | 50% of the top 10 - and made a loss - If it was a Whelk Stall you would panic if they got hold of the other 50%? | deutsch4 | |
01/6/2021 11:22 | Awful results Shocking Revenue of £1.3m (NB they bought this Revenue in with acquisition of Springer which had revenues of E2m so it's gone backwards in reality!) Losses still stinking the place out | the stigologist | |
24/5/2021 17:45 | ragnarr Good point, there is no ramping really, just the odd troll. | yump | |
24/5/2021 16:38 | Thanks for sharing. Yeah he's a genius and owns nearly 7% of Dmtr which gives me great confidence that the tech is awesome. | wololol | |
24/5/2021 16:33 | Prof Lee Cronin is a versatile chap eh! | jpuff | |
24/5/2021 14:10 | Not a holder, but if you have the right product area and depth in AI drug development you can get reveune generating news like this from the FT last week, Exscientia are based in Oxford "Bristol-Myers Squibb has agreed to pay up to $1.2bn to enter a drug discovery collaboration with artificial intelligence start-up Exscientia as the Big Pharma company bets on the power of the technology to turbocharge drug development. " DMTR also have a deal with BMS though presumably much much smaller, but if they cannot grow their revenues significantly in this climate they have problems | banshee | |
24/5/2021 13:44 | Really need some revenue generating news. Lets hope they are like no 9 buses when they come:-) | ragnarr | |
24/5/2021 13:00 | I am expecting revenues of about £1.8million. anything above that would be great. More importantly would like to see the progress of the major collaborations. I understand they have consolidated the workforce so expenses should be lower as well. | wololol | |
24/5/2021 12:58 | ShareTalkNews@Share | ragnarr | |
24/5/2021 10:26 | Looks like whoever selling has stopped. This could be the start of a re-rate. There you go I am talking it up because it's so undervalued. Had some more this AM. | wololol | |
24/5/2021 10:13 | whos talking it up Yump | ragnarr | |
24/5/2021 09:58 | If anyone is holding here expecting anything unexpected from results, you should just get out. This is a period for picking an investment price that might look good, looking quite a long way ahead. The 2-3p movements are just noise, but I suppose if it floats some boats day to day to talk it up or down... although the reality is it makes no difference. | yump | |
24/5/2021 09:50 | Hopefully 2p was the bottom! | parob | |
24/5/2021 09:48 | Not sure if my eyes are working - All i see is blue | ragnarr | |
16/5/2021 18:22 | Results due soon so can't rule out | thiopia | |
16/5/2021 14:11 | Silly boy/girl | ragnarr | |
15/5/2021 18:26 | Back to 1.5 next week 🤣🤣 | purchaseat_thebottom | |
29/4/2021 14:20 | Nice bit of blue today - news is long overdue | ragnarr |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions